BSX vs COPART
Boston Scientific Corp (BSX) versus COPART (COPART) — a side-by-side from cached financials, not a winner call.
Boston Scientific Corp (BSX) is a medical devices company listed on US.
COPART (COPART) common stock.
Latest reported BSX revenue for 2026-06-30 was $10.65B. Net income was $2.24B. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
COPART does not have a complete income-statement cache yet.
BSX currently screens at market cap $71.81B and trailing P/E 20.2.
Not investment advice. Open the BSX and COPART stock pages for the full models.
Not investment advice.